首页 | 本学科首页   官方微博 | 高级检索  
检索        

慢性肾脏病3~5期非糖尿病非透析患者动脉僵硬度及其对预后的影响
引用本文:王宓,张昕,隋准,白丽,王琰,左力,王梅.慢性肾脏病3~5期非糖尿病非透析患者动脉僵硬度及其对预后的影响[J].中华临床医师杂志(电子版),2020,14(3):170-174.
作者姓名:王宓  张昕  隋准  白丽  王琰  左力  王梅
作者单位:1. 100044 北京大学人民医院肾内科
基金项目:中华医学会临床医学科研专项资金(09010050160);首都卫生发展科研专项项目(首发2011-4022-04)。
摘    要:目的检测慢性肾脏病(CKD)3~5期非糖尿病非透析患者动脉僵硬度,并探讨其对患者心脑血管死亡及全因死亡的影响。 方法纳入北京大学人民医院2006年4月至2012年11月收治的CKD 3~5期非糖尿病非透析住院患者161例,所有患者住院后检测颈-股动脉脉搏波速度(CFPWV)。根据CFPWV水平,将患者分为CFPWV正常组(CFPWV<12 m/s)和CFPWV升高组(CFPWV≥12 m/s),随访入选患者的生存情况。采用Kaplan-Meier法对患者的生存情况进行评价,Cox比例风险回归对影响患者预后的因素进行分析。 结果平均随访时间为(99.15±49.57)个月。CFPWV升高组心脑血管死亡率及全因病死率均明显高于CFPWV正常组[37.6%(19/51) vs 11.0%(9/82),50.7%(26/51) vs 20.7%(17/82),P均<0.05]。Kaplan-Meier曲线显示CFPWV升高组心脑血管病死率及全因病死率均明显高于CFPWV正常组(P<0.05)。多因素Cox回归分析显示,年龄及CFPWV是患者心血管死亡及全因死亡的独立危险因素,此外,白蛋白及血红蛋白还是全因死亡的独立危险因素(P<0.05)。 结论高CFPWV的CKD 3~5期非糖尿病非透析患者心脑血管死亡率及全因死亡率均明显高于CFPWV正常的CKD患者,且CFPWV升高是CKD 3~5期非糖尿病非透析患者发生心脑血管死亡及全因死亡的独立危险因素。

关 键 词:慢性肾脏病  非糖尿病非透析  动脉僵硬度  预后  
收稿时间:2020-02-17

Impact of arterial stiffness on prognosis in non-diabetic pre-dialysis patients with stages 3-5 chronic kidney disease
Wang Mi,Zhang Xin,Sui Zhun,Bai Li,Wang Yan,Zuo Li,Wang Mei.Impact of arterial stiffness on prognosis in non-diabetic pre-dialysis patients with stages 3-5 chronic kidney disease[J].Chinese Journal of Clinicians(Electronic Version),2020,14(3):170-174.
Authors:Wang Mi  Zhang Xin  Sui Zhun  Bai Li  Wang Yan  Zuo Li  Wang Mei
Institution:1. Department of Nephrology, People's Hospital of Peking University, Beijing 100044, China
Abstract:Objective To assess the impact of arterial stiffness on prognosis in non-diabetic predialysis patients with stages 3-5 chronic kidney disease(CKD).Methods A total of 161 non-diabetic predialysis patients who suffered from stages 3-5 CKD were enrolled in this study between April 2006 and November 2012.An automatic pulse wave velocity(PWV)measuring system was used to measure carotidfemoral PWV(CFPWV).According to CFPWV level,we divided the patients into a high CFPWV group(CFPWV≥12 m/s)and a normal group(CFPWV<12 m/s).The patients were followed for the occurrence of cardiovascular death and all-cause death.Kaplan-Meier method was used for survival analysis and Cox proportional hazard regression model was used to identify the risk factors.Results The mean follow-up duration was(99.15±49.57)months.The incidence of cardiac-cerebral vascular death and all-cause death was significantly higher in the high CFPWV group than in the control group37.6%(19/51)vs 11.0%(9/82),50.7%(26/51)vs 20.7%(17/82),P<0.05].Kaplan-Meier curve analysis for overall survival and cardiaccerebral vascular event free survival showed that cardiac-cerebral vascular mortality and all-cause mortality were significantly higher in the high CFPWV group than in the control group(P<0.05).Multivariate Cox regression analysis revealed that increased CFPWV and age were the independent risk factors for cardiaccerebral vascular mortality and all-cause mortality,and decreased albumin and hemoglobin were the independent risk factors for all-cause mortality(P<0.05).Conclusion The incidence of cardiac-cerebral vascular mortality and all-cause mortality is significantly higher in stages 3-5 CKD patients with elevated CFPWV than in those with normal CFPWV.Elevated CFPWV is one of independent risk factors for cardiaccerebral vascular mortality and all-cause mortality in non-diabetic pre-dialysis patients with CKD.
Keywords:Chronic kidney disease  Non-diabetic pre-dialysis  Arterial stiffness  Prognosis
本文献已被 维普 等数据库收录!
点击此处可从《中华临床医师杂志(电子版)》浏览原始摘要信息
点击此处可从《中华临床医师杂志(电子版)》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号